Clinical trial
Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children…
NCT00091702 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00091702 |
|---|---|
| Title | Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents |
| Official title | A Phase I/II Randomized Trial of the Safety and Immunogenicity of Cold Adapted Influenza Vaccine (FluMist) in HIV-Infected Children and Adolescents |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Influenza |
| Intervention type | Biological |
| Interventions | Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated influenza vaccine (IAIV) |
| Enrollment | 300 |
| Completion | Jan 1, 2006 |
| First posted | Sep 20, 2004 |
| Last update posted | Nov 1, 2021 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: